FDA Approved: ENDARI — Supplemental Application (Emmaus Medical, Inc.)

View source ↗

Summary

FDA approved a supplemental application for ENDARI (L-glutamine) from Emmaus Medical, Inc., updating its regulatory status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sickle Cell Disease

Drugs mentioned

• ENDARI (GLUTAMINE)

Snippet

SUPPL AP for ENDARI (GLUTAMINE)